PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Maternal-Fetal Medicine Department, General Hospital of Mexico, \'Dr Eduardo Liceaga\', Mexico City, Mexico.\', \'Clinical Research Branch, National Institute of Perinatology, Mexico City, Mexico.\', \'ABC Medical Center, Medical Association, Mexico City, Mexico.\', \'Chinese University of Hong Kong, Hong Kong SAR.\', \'Research Direction, National Institute of Perinatology, Mexico City, Mexico.\', \'Immunobiochemistry Department, National Institute of Perinatology, Mexico City, Mexico.\', \'Laboratory of Immunogenomics and Metabolic Diseases, INMEGEN, Mexico City, Mexico.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1002/uog.24798
?:doi
?:hasPublicationType
?:journal
  • Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
is ?:pmid of
?:pmid
?:pmid
  • 34664753
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Increased levels of soluble fms-like tyrosine kinase-1 are associated with adverse outcome in pregnant women with COVID-19.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all